Rosetta Genomics Raises $6M in Direct Offering, Regains Nasdaq Compliance with Bid Requirement | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics said after the close of the market on Thursday that it has netted proceeds of about $6 million from a direct offering, and that it has regained compliance on at least one of two Nasdaq listing requirements that it previously failed to meet.

It added that it believes it has regained compliance with the second listing requirement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.